BCG
SNY icon

BayBridge Capital Group’s Sanofi SNY Stock Holding History

BayBridge Capital Group’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-26,612
Closed -$1.29M – 102
2025
Q2 		$1.29M Buy
26,612
+1,343
+5% +$68.6K 0.83% 43
2025
Q1 		$1.4M Buy
+25,269
New +$1.37M 1.01% 37

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

BayBridge Capital Group's SNY Position: Q3 2025 in Review

BayBridge Capital Group sold out of Sanofi (SNY) in Q3 2025, closing a stake of 26,612 shares — an estimated $1.29M sold.

BayBridge Capital Group first reported a position in SNY in Q1 2025 and held it in 2 quarters. The position peaked at $1.4M in Q1 2025. 710 funds tracked by Wall St. Rank hold SNY as of Q3 2025.

  • BayBridge Capital Group reported no remaining Sanofi position as of Q3 2025 after selling out during the quarter.
  • BayBridge Capital Group sold 26,612 Sanofi shares in Q3 2025, an estimated $1.29M.
  • BayBridge Capital Group first reported a position in Sanofi in Q1 2025 and held it in 2 quarters.
  • BayBridge Capital Group's Sanofi position peaked at $1.4M in Q1 2025.
  • 710 funds tracked by Wall St. Rank held Sanofi as of Q3 2025.

Based on BayBridge Capital Group's 13F filing for Q3 2025, filed 15 Oct 2025.